Evidence map›Paper›PMID 36393917›Full record

ArticleJACC. Asia2022

Incidence, Timing, and Causes of Late Bleeding After TAVR in an Asian Cohort.

Masanori Yamamoto, Toshiaki Otsuka, Tetsuro Shimura, Ryo Yamaguchi, Yuya Adachi, Ai Kagase, Takahiro Tokuda, Satoshi Tsujimoto, Yutaka Koyama, Fumiaki Yashima and 12 more

Abstract read
In one paragraph

Article in JACC. Asia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Masanori YamamotoDepartment of Cardiology, Toyohashi Heart Center, Toyohashi, Japan.
Toshiaki OtsukaDepartment of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan.
Tetsuro ShimuraDepartment of Cardiology, Toyohashi Heart Center, Toyohashi, Japan.
Ryo YamaguchiDepartment of Cardiology, Toyohashi Heart Center, Toyohashi, Japan.
Yuya AdachiDepartment of Cardiology, Toyohashi Heart Center, Toyohashi, Japan.
Ai KagaseDepartment of Cardiology, Nagoya Heart Center, Nagoya, Japan.
Takahiro TokudaDepartment of Cardiology, Nagoya Heart Center, Nagoya, Japan.
Satoshi TsujimotoDepartment of Cardiology, Nagoya Heart Center, Nagoya, Japan.
Yutaka KoyamaDepartment of Cardiology, Nagoya Heart Center, Nagoya, Japan.
Fumiaki YashimaDepartment of Cardiology, Saiseikai Utsunomiya Hospital, Tochigi, Japan.
Norio TadaDepartment of Cardiology, Sendai Kosei Hospital, Sendai, Japan.
Toru NaganumaDepartment of Cardiology, New Tokyo Hospital, Chiba, Japan.
Masahiro YamawakiDepartment of Cardiology, Saiseikai Yokohama City Eastern Hospital, Yokohama, Japan.
Futoshi YamanakaDepartment of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan.
Shinichi ShiraiDepartment of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
Kazuki MizutaniDepartment of Cardiology, Kindai University, Osaka, Japan.
Minoru TabataDepartment of Cardiovascular Surgery, Tokyo Bay Urayasu-Ichikawa Medical Center, Chiba, Japan.
Hiroshi UenoDepartment of Cardiology, Toyama University Hospital, Toyama, Japan.
Kensuke TakagiDepartment of Cardiology, Ogaki Municipal Hospital, Gifu, Japan.
Yusuke WatanabeDepartment of Cardiology, Teikyo University School of Medicine, Tokyo, Japan.
Kentaro HayashidaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
OCEAN-TAVI Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Data regarding the incidence, predictive factors, and clinical outcomes of post-transcatheter aortic valve replacement (TAVR) bleeding is limited in the Asian cohort. Objectives: This study sought to assess the predictors and prognostic impact of post-TAVR late bleeding. Methods: This study used the Japanese multicenter registry data to analyze 2,518 patients (mean age: 84.3 ± 5.2 years) who underwent TAVR. Late bleeding was defined as any postdischarge bleeding events after TAVR. Baseline characteristics, predictive factors, and clinical outcomes including death and rehospitalization were assessed in patients with and without late bleeding events. Results: The cumulative incidence rate of all and major late bleeding and ischemic stroke were 7.4%, 5.2%, and 3.4%, respectively, 3 years after TAVR. The independent predictive factors of late bleeding were low platelet count, high score (≥4) on the clinical frailty scale, and a New York Heart Association functional class III/IV. The cumulative mortality rates up to 3 years were significantly higher in patients with late bleeding than in those without bleeding ( Conclusions: Late bleeding after TAVR was not a rare complication, and it significantly increased long-term mortality. It should be carefully managed, especially when it is predictable in the high-risk cohort, and efforts should be taken to reduce bleeding complications even after a successful procedure.

Indexed as

AF, atrial fibrillationBARC, Bleeding Academic Research ConsortiumCFS, clinical frailty scaleclinical outcomeDAPT, dual antiplatelet therapyGI, gastrointestinallate bleedingNYHA, New York Heart AssociationOAC, oral anticoagulantOR, odds ratioPCI, percutaneous coronary interventionSPAT, single antiplatelet therapyTAVR, transcatheter aortic valve replacementtranscatheter aortic valve replacement

Identifiers

PMID36393917
PMCPMC9660329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.